Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Follow-up of patients with R/R FLT3- mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

Alexander E. Perl, Richard A. Larson, Nikolai Alexandrovich Podoltsev, Stephen Anthony Strickland, Eunice S. Wang, Ehab L. Atallah and 15 more

Rank
33 of 6,257
Percentile
top 0.6%
Where
Blood, 2022
Citations
149

From the 2022 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.